Artikel
Hypocalcaemia as a prognostic factor of mortality in moderate and severe traumatic brain injury
Suche in Medline nach
Autoren
Veröffentlicht: | 21. Mai 2013 |
---|
Gliederung
Text
Objective: Our main objective was to evaluate whether serum hypocalcaemia (defined as < 2.1 mmol/L (8.5 mg/dL)) is a prognostic factor for mortality in the first 72 hours after moderate and severe TBI.
Method: We developed an ambispective comparative case-control study. We evaluated clinical profiles from included patients from January 2005 to July 2009 and we prospectively recruited additional patients for evaluation from August 2009 to July 2011. Patients were between 1 and 89 years old and had a Glasgow Coma Scale (GCS) of 3-12 points following TBI.
Results: Retrospectively (January 2005 to July 2009) we compiled data from 81 patients. Prospectively (August 2009 to July 2011) we recruited 41 patients with moderate and severe TBI that fulfilled the inclusion criteria. A total of 122 patients with a mean age of 21 years old (range: 1 to 89) were included. From the studied patients, 101 (82.27%) were of the male gender and 21 (17.21%) of female gender. One hundred and thirteen (92.73%) patients survived and 9 (7.37%) died. The demographic variables, clinical variables, basal pH levels, associated lesions, intubation days and number of days in the intensive care unit are shown in Table 1. In Table 2 are shown the chemistry variables and blood cellularity from day 0 and 3. In Table 3 are shown the hypocalcemia frequency in the study groups. We calculated an OR of 5.2 (IC 4.48 to 6.032) for hypocalcemia on day three, which was associated with death. The adjusted variables in the logistic regression final model were: serum calcium on day three (OR 3.5, IC 95% 1.12 to 13.61 p<0.028) and anisocoria (OR 8.24 IC 95% 1.3 to 67.35 p<0.019) obtaining an adjusted R2 of 0.22 (p<0.005).
Conclusions: As seen in our study, the serum levels of calcium on day three could be useful for the prediction of mortality in patients with moderate and severe TBI.